Crossmark

Programmable nanomicelles rewire myeloid immunity for durable control of primary and metastatic breast cancer

Crossref DOI link: https://doi.org/10.1038/s41467-026-70859-5

Published Online: 2026-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Jie https://orcid.org/0000-0002-8636-2015
Chang, Di

Li, Yingbo https://orcid.org/0000-0003-0453-4862
Xu, Zuoyu

Li, Daoshuang

Xu, Xiaoxuan

Zhang, Zhiqi https://orcid.org/0000-0003-3390-1254
Li, Yize https://orcid.org/0009-0003-6385-0942
Zhang, Jianqiong

Xie, Jinbing https://orcid.org/0000-0002-6071-0878
Xiao, Zebin https://orcid.org/0000-0002-3311-7403
Ju, Shenghong https://orcid.org/0000-0001-5041-7865
License Information

Text and Data Mining valid from 2026-03-17

Accepted Manuscript valid from 2026-03-17
More Information

Article History

Received: 11 May 2025

Accepted: 9 March 2026

First Online: 17 March 2026

Competing interests

: The authors declare no competing interests.